These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6021620)

  • 1. [Clinical experimentation with a combination of substances having vasodilator effects on the cerebral circulation].
    Barbi G; Tallone G
    Minerva Med; 1967 Feb; 58(13):489-91. PubMed ID: 6021620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclospasmol 400 in cerebral circulation insufficiency].
    Warot P
    Lille Med; 1973; 18(7):842-4. PubMed ID: 4603446
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative evaluation of the effect of vasodilator drugs on the cerebral vessels of patients with cerebral atherosclerosis (rheoencephalographic studies)].
    Eninie GI; Smeltere ES
    Klin Med (Mosk); 1972 Sep; 50(9):39-44. PubMed ID: 4652968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebrosclerosis, motor recovery and mental disorders].
    Niquet G
    Lille Med; 1972 Feb; 17():Suppl 2:187-90. PubMed ID: 5034401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical tests, in psychiatry, of a modifier of cerebral circulation: 1035 M.D].
    Porot M; Couadau A; Petit G; Lajoinie J
    Ann Med Psychol (Paris); 1968 Mar; 1(3):442-7. PubMed ID: 5670017
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effects of sodium nicotinate and dihydroergotamine on cerebral circulation. Rheographic studies in subjects with cerebral vascular diseases].
    Arrigo F; Turiano S; Consolo F
    Boll Soc Ital Biol Sper; 1973 Mar; 49(5):292-7. PubMed ID: 4786565
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic results with the cerebral vasodilator agent Instenon].
    Salomon K
    Wien Klin Wochenschr; 1967 Jun; 79(26):546-8. PubMed ID: 5585427
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.
    Smith WL; Lowrey JB; Davis JA
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):613-8. PubMed ID: 4972756
    [No Abstract]   [Full Text] [Related]  

  • 14. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years.
    Hunyi L
    Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R; Haas R
    Arzneimittelforschung; 1967 Mar; 17(3):313-7. PubMed ID: 5631222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of ustimon on cerebral circulation].
    Vas M; Solti F; Gara I
    Wien Klin Wochenschr; 1969 Jan; 81(4):69-72. PubMed ID: 5812950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medical treatment of cerebral vascular diseases in aged patients].
    Chatin B
    Therapeutique; 1969 Nov; 45(9):885-7. PubMed ID: 5365415
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.